Wellinks

Wellinks is a chronic pulmonary disease management company based in New Haven, Connecticut. Founded in 2012, it focuses on providing virtual-led cardiopulmonary care solutions, particularly for chronic obstructive pulmonary disease (COPD). The company has raised a total of $44.8 million in funding, with its latest round bringing in $25 million about four years ago.

Wellinks offers a comprehensive virtual-led cardiopulmonary care model that includes virtual pulmonary rehabilitation, personalized coaching, and device-based monitoring through connected devices and a smartphone app. Their approach utilizes predictive analytics and machine learning to identify potential health issues before they require emergency care. Recently, Wellinks expanded its capabilities by acquiring Spire Health, enhancing its services to include management for congestive heart failure (CHF). The company serves individual patients, healthcare payers, and value-based care organizations, partnering with various healthcare entities to improve COPD management.